CoreAge Rx vs Levers Health
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Levers Health head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 63 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make Levers Health a bad call — it's best for readers comparing compounded low-dose and any-dose programs who verify the full upfront payment and subscription agreement. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | Levers Health |
|---|---|---|
| Brief Score | 94/100 (A) | 63/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Current selected-plan quote unconfirmed Homepage starts at $147; exact term, supplied quantity and full selected payment not established. Earlier $247/month at 1.25 mg is historical. Terms require a two-month subscription and 48-hour advance cancellation; prepaid duration nonrefundable after first shipment. NJ coverage differs by page. Full price detailsCompounded semaglutide injection offered; complete selected-plan quote unknown; homepage starts at $147 but current readable product selector does not establish the full selected charge; earlier $247/month listing for a 1.25 mg dose is historical |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | Low-dose $296 / any-dose $396 monthly Six-month options show $196/$296 monthly equivalents; full selected upfront charge unconfirmed. Earlier $296/month at 5 mg is historical. Low-dose and any-dose are distinct. Two-month minimum/48-hour cancellation in terms; pharmacy processing and first shipment have separate refund limits. Full price detailsCompounded tirzepatide injection offered; complete selected-plan quote unknown; one-month low-dose $296/month or any-dose $396/month advertised; six-month equivalents $196/$296 monthly without a full selected upfront charge; earlier $296/month listing for a 5 mg dose is historical |
| Coverage | US only; restrictions by state, confirmed at intake | Published state lists are limited and differ on New Jersey; confirm current product/pharmacy eligibility before purchase |
| Brand-name access | Not confirmed | The reviewed compounded programs are not an established branded GLP-1 service; brand comparisons do not identify an available brand prescription. |
| Oral / sublingual | Injection only | Unconfirmed |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
Levers Health: Low-dose and any-dose prices differ. Full selected prepaid charge unconfirmed; terms require2months/48h cancellation, and prepaid durations are nonrefundable after first shipment. NJcoverage differs by page.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.